Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Voyager Therapeutics, Inc.

Present preclinical data on early pipeline and non-human primate capsid discovery

Delivered by the deadline

AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.

Announced
25 Feb 2021
Due
30 Jun 2021
Delivered
May 2021
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“Voyager expects to provide preclinical data on its early pipeline progress as well as its novel capsid discovery efforts in non-human primates at scientific meetings”

What we found

Evidence strength A What the grades mean

Later 10-Q and 10-K filings say Voyager presented new preclinical data on novel AAV capsids in non-human primates in May 2021, before the end of the first-half deadline.

  • A
    Voyager Therapeutics, Inc. 10-Q filed 2021-08-09 Regulatory filing · published 9 Aug 2021 · retrieved 26 Oct 2026 · kept permanently by the SEC
    “In May 2021, we presented new data demonstrating that we have developed a series of novel AAV capsids” ✓ confirmed on the page
  • A
    Voyager Therapeutics, Inc. 10-Q filed 2021-11-02 Regulatory filing · published 2 Nov 2021 · retrieved 26 Oct 2026 · kept permanently by the SEC
    “In May 2021, we presented new data demonstrating that we have developed a series of novel AAV capsids” ✓ confirmed on the page
  • A
    Voyager Therapeutics, Inc. 10-K filed 2022-03-08 Regulatory filing · published 8 Mar 2022 · retrieved 26 Oct 2026 · kept permanently by the SEC
    “In May 2021, we presented new data demonstrating that we have developed a series of novel AAV capsids” ✓ confirmed on the page

Checked 26 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Clinical readout
Indicative materiality
Medium rules
Action
Present
Deliverable
Preclinical data presentations on pipeline and non-human primate capsid work
Language
Expected (“expects”, “plans”)
In the company’s control
Medium
Specificity
Medium

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.

Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works

Are you Voyager Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-VYGR-024611 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.